JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EDDY, N. B.
Right arrow Articles by REID, J. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by EDDY, N. B.
Right arrow Articles by REID, J. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 52, Issue 4, 468-493, 1934
Copyright © 1934 by American Society for Pharmacology and Experimental Therapeutics


STUDIES OF MORPHINE, CODEINE AND THEIR DERIVATIVES VII. DIHYDROMORPHINE (PARAMORPHAN), DIHYDROMORPHINONE (DILAUDID), AND DIHYDROCODEINONE (DICODIDE)

NATHAN B. EDDY 1 and JOHN G. REID 1

1 From the Laboratory of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

Dihydromorphine, like other hydrogenated derivatives, is less convulsant and more analgesic than morphine. Its emetic effect is about equal to that of morphine, it produces less general depression, and is about four times as toxic as the latter substance.

Dihydromorphinone (Dilaudid) is more active than morphine in some respects, but it is also more toxic. A comparison of the ratios of its greater effectiveness and the ratio of its greater toxicity would not lead one to expect a greater margin of safety. Its emetic effect is qualitatively like that of morphine, but quantitatively favors a lower incidence of vomiting at any dose. Its repeated administration to dogs and monkeys leads to the development of tolerance, a little less rapidly than with morphine, and to the occurrence of "abstinence" symptoms which are only slightly less severe than after similar administration of morphine.

Dihydrocodeinone (Dicodide) is more active than codeine but in most respects less active than morphine. Compared to dihydromorphinone, from which it differs only in the methylation of the phenolic hydroxyl, it shows the usual difference associated with this chemical change, increased convulsant action and decreased activity in other respects. Its repeated administration to dogs and monkeys leads to the development of tolerance but more slowly than with morphine or Dilaudid and to the occurrence of "abstinence" symptoms which are less severe than with either of the other two substances.

Submitted on September 19, 1934







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1934 by the American Society for Pharmacology and Experimental Therapeutics.